Samluta 40mg Capsule
In stock
Description
Samluta 40 mg capsules contain Enzalutamide, an androgen receptor inhibitor used to treat metastatic and non-metastatic castration-resistant prostate cancer (mCRPC/nmCRPC). It works by blocking testosterone from binding to cancer cells, thereby inhibiting tumor growth and inducing cell death. The typical dose is 160 mg (four 40 mg capsules) daily.
Specifications
| Strength | 40mg |
|---|---|
| Pack | 28 Tablets |
| Storage | Store below 30°C |
| Uses | Prostate Cancer |
| Main Ingredients | Enzalutamide |
